Related Experiment Videos
Immune responses in interleukin-2-deficient mice
T M Kündig1, H Schorle, M F Bachmann
1Institute of Experimental Immunology, University of Zürich, Switzerland.
Summary
Interleukin-2 (IL-2) is crucial for T cell responses in vitro. However, IL-2 deficient mice show largely normal in vivo immune functions, challenging IL-2
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Interleukin-2 (IL-2) is a cytokine critical for T cell proliferation and function.
- Previous in vitro studies strongly suggested IL-2's indispensable role in adaptive immune responses.
- The in vivo significance of IL-2 in T cell induction and overall immunity remained to be fully elucidated.
Purpose of the Study:
- To investigate the role of interleukin-2 (IL-2) in T cell induction and immune responses in vivo.
- To compare in vitro and in vivo findings regarding the necessity of IL-2 for adaptive immunity.
- To assess the impact of IL-2 deficiency on cytotoxic T cells, T helper cells, B cells, and natural killer cells.
Main Methods:
- Utilized genetically engineered mice lacking the interleukin-2 (IL-2) gene.
- Assessed in vitro secondary antiviral T cell responses with and without IL-2 supplementation.
- Evaluated in vivo primary and secondary immune responses against vaccinia virus and lymphocytic choriomeningitis virus.
- Measured B cell reactivity, T helper cell function, and natural killer cell activity.
Main Results:
- In vitro T cell responses were absent without IL-2, confirming its in vitro necessity.
- In vivo, cytotoxic T cell responses were normal in IL-2 deficient mice.
- T helper cell responses were delayed but functional, B cell reactivity was unimpaired, and natural killer cell activity was reduced but inducible.
Conclusions:
- In vivo immune responses in IL-2-deficient mice are largely normal, questioning the absolute requirement of IL-2 suggested by in vitro studies.
- These findings highlight potential discrepancies between in vitro and in vivo immune system functions.
- The study suggests that other costimulatory signals or cytokines may compensate for IL-2 deficiency in vivo.